Ergoteles LLC Horizon Therapeutics Public LTD CO Transaction History

Ergoteles LLC

$68.2 Billion
Q3 2023

A detailed history of Ergoteles LLC transactions in Horizon Therapeutics Public LTD CO stock. As of the latest transaction made, Ergoteles LLC holds 121,905 shares of HZNP stock, worth $0. This represents 20.67% of its overall portfolio holdings.

Number of Shares

121,905

Previous 96,905 25.8%

Holding current value

Previous $9.97 Million 141413.03%

% of portfolio

20.67%

Previous 0.49%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $2.47 Million - $2.89 Million	25,000 Added 25.8%	121,905 $14.1 Billion
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $1.66 Million - $1.94 Million	-17,269 Reduced 15.13%	96,905 $9.97 Million
Q1 2023 May 10, 2023	BUY	$107.32 - $113.5 $3.23 Million - $3.42 Million	30,114 Added 35.82%	114,174 $12.5 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $3.78 Million - $6.9 Million	60,648 Added 259.05%	84,060 $9.57 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $1.38 Million - $1.98 Million	23,412 New	23,412 $1.45 Million
Q2 2022 Aug 12, 2022	SELL	$79.4 - $116.36 $647,983 - $949,613	-8,161 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $705,273 - $896,159	8,161 New	8,161 $859,000
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $4.28 Million - $5.14 Million	-46,562 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$86.24 - $95.92 $4.02 Million - $4.47 Million	46,562 New	46,562 $4.36 Million
Q4 2020 Feb 11, 2021	SELL	$67.0 - $84.39 $10.2 Million - $12.9 Million	-152,643 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $8.43 Million - $12.2 Million	152,643 New	152,643 $11.9 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.

Account